PXL/HO/Cir-064/2017-18                                                                                                                             Date: 21.09.2017

All the Members of Council,

Dear Sir/Madam,

Members are aware of that Government of India is very keen on reducing import dependency for KSMs, APIs and Intermediates to make India self-reliant and  in tune with the same Pharmexcil with the support of Commerce Ministry, has organized few Interactive Meetings with Industry and CSIR Labs and other Institutions. Consultations with all stakeholders are going on and Government is contemplating to bring out a Pharma manufacturing Policy in this regard. 

Based on the study made by Pharmexcil and information shared by member companies, Council have identified about 50 APIs, KSMs and Intermediates which are being largely imported. Pharmexcil to take this initiative forward, invited CSIR Labs, prominent Research Institutes and industry to evolve a strategy to way forward on the products .In this connection Pharmexcil is organising a Round Table Conference on "Product Development (APIs, KSMs & Intermediates) and Process Improvements in Bulk Drug Industry" on 23^rd Sep.2017 at HICC, Hyderabad on the occasion of 13 th AGM. 

We are happy to inform that Dr S Chandrasekhar-IICT, Dr Ram A Vishwakarma- IIIM, Dr Rakesh Kumar Mishra- CCMB, Dr (Mrs) Madhu Dikshit,CDRI have confirmed their participation. Senior Scientists from NCL, ICT, CIMAP are also joining the event.

  The Round table meet is focused at ascertaining the following:

• Immediate needs of industry for APIs, KSMs and Intermediates
• To integrate it with CSIR labs for developing these largely imported APIs.
• Devising an action plan for top ten products (APIs, KSMs and Intermediates) and   to identify labs would be working on these products.
• List of Companies interested to support and partner with CSIR labs
• Investment aspects for developing these top ten products and fixing timelines
• Financial assistance from Government side
• Exclusivity agreements to the manufacturers for the producing top ten products

In addition to the above points, we would also be discussing on the process improvement requirements of the Bulk Drug industry. The details of the programme are given below for your information:

Since it would be an ideal forum to associate with different National Laboratories of repute and also to put forth the requirements of industry and your products of import dependency in particular, we invite CEOs / R&D Heads to take part in this important Conference.

There is no Registration Fee to participate in the Conference. Please register by sending a mail to biodesk@pharmexcil.com at the earliest possible, for enabling Council to make necessary arrangements.

Since seats are limited, we request the members to register for the Conference immediately to avoid last minute rush.

With regards,

Uday Bhaskar

Director General

Encl:

Previous Circular